作者：
Voorhees,P.M. [1]
;
Manges,R.F. [2]
;
Sonneveld,P. [3]
;
Jagannath,S. [4]
;
Somlo,G. [5]
;
Krishnan,A. [6]
;
Lentzsch,S. [7]
;
Frank,R.C. [8]
;
Zweegman,S. [9]
;
Wijermans,P.W. [10]
;
Orlowski,R.Z. [11]
;
Kranenburg,B. [12]
;
Hall,B. [13]
;
Casneuf,T. ;
Qin,X. ;
VandeVelde,H. ;
Xie,H. ;
Thomas,S.K.
作者单位：
Department of Haematology, Haga Hospital, the Hague, Netherlands
[1]
Oncology Division, Whittingham Cancer Center at Norwalk Hospital, Norwalk, CT, United States
[2]
Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX
[3]
Investigative Clinical Research of Indiana, LLC, Indianapolis, IN, United States
[4]
Division of Hematology-Oncology, University of North Carolina Lineberger Comprehensive Cancer
[5]
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center
[6]
Janssen Research and Development, Beerse, Belgium
[7]
Division of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY, United States
[8]
Janssen Biologics Europe, Leiden, Netherlands
[9]
Department of Haematology, Erasmus Medical Centre and University, Rotterdam, Netherlands
[10]
Division of Hematology-Oncology, University of Pittsburg School of Medicine and Cancer Institute
[11]
Department of Haematology, Vrije Universiteit Medical Centre, Amsterdam, Netherlands
[12]
Janssen Research and Development, Spring House, PA, United States
[13]
发布时间
2013-11-20
换一批
